1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Psoriasis in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (36.84) | 18.7374 |
| 1990's | 6 (31.58) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, H; Kanzaki, K; Kawakami, Y; Maruoka, S; Miki, Y; Mori, Y; Murakami, M; Nagasaki, Y; Okamoto, K; Sawazumi, R; Suzuki-Yamamoto, T; Takahashi, Y; Tamenobu, A; Toda, K; Tsukayama, I; Yamamoto, K | 1 |
| Enk, AH; Hadaschik, EN; Hartl, D; Hoffmann, JHO; Schaekel, K | 1 |
| Claßen, A; Danker, K; Forkel, S; Hildmann, A; John, SM; Schön, M; Schön, MP | 1 |
| Bambach, I; Huettner, B; Koefeler, H; Mayer, G; Schön, MP; Singh, TP; Wallbrecht, K; Wolf, P | 1 |
| Ananthaswamy, HN; Bucana, C; Byrne, S; Matsumura, Y; Nghiem, DX; Ullrich, SE; Walterscheid, JP; Wolf, P | 1 |
| Czarnetzki, B | 1 |
| Cunningham, FM; Daniel, R; Mallet, AI | 1 |
| Barr, RM; Courtney, F; Greaves, MW; Judge, MR; Kobza Black, A; Mallet, AI | 1 |
| Elbers, ME; Gerritsen, MJ; van de Kerkhof, PC | 1 |
| Liu, BJ; Zhang, HT; Zheng, MR | 1 |
| Goto, Y; Ishimaru, S; Izaki, S; Kitamura, K; Matsuzaki, M; Yamamoto, T; Yudate, F | 1 |
| Greaves, MW; Judge, MR | 1 |
| Dubertret, L; Michel, L | 1 |
| Camp, RD; Greaves, MW | 1 |
| Mallet, AI; Rollins, K | 1 |
| Cunningham, FM; Greaves, MW; Mallet, AI; Wong, E | 1 |
| Pickett, WC; Ramesha, CS; Soter, N | 1 |
| Cunningham, FM; Mallet, AI | 1 |
2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Psoriasis
| Article | Year |
|---|---|
Leukotriene B4 and platelet-activating factor in human skin.
Topics: Dermatitis; Humans; Leukotriene B4; Platelet Activating Factor; Psoriasis; Skin Physiological Phenomena | 1992 |
Prostaglandins, leukotrienes, phospholipase, platelet activating factor, and cytokines: an integrated approach to inflammation of human skin.
Topics: Annexins; Arachidonic Acid; Arachidonic Acids; Dermatitis; Glycoproteins; Humans; Interleukin-1; Leukotriene B4; Lipoxygenase; Phospholipases; Platelet Activating Factor; Prostaglandins; Psoriasis | 1988 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Psoriasis
| Article | Year |
|---|---|
The effect of topical application of the platelet-activating factor-antagonist, Ro 24-0238, in psoriasis vulgaris--a clinical and immunohistochemical study.
Topics: Adult; Chronic Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Platelet Activating Factor; Polyunsaturated Alkamides; Psoriasis; Pyridines | 1994 |
16 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Psoriasis
| Article | Year |
|---|---|
Malabaricone C derived from nutmeg inhibits arachidonate 5-lipoxygenase activity and ameliorates psoriasis-like skin inflammation in mice.
Topics: Animals; Arachidonate 5-Lipoxygenase; Inflammation; Leukotrienes; Mice; Myristica; Platelet Activating Factor; Psoriasis | 2022 |
Dimethyl fumarate modulates neutrophil extracellular trap formation in a glutathione- and superoxide-dependent manner.
Topics: Analysis of Variance; Antioxidants; Caspases; Cells, Cultured; Dermatologic Agents; Dimethyl Fumarate; Dose-Response Relationship, Drug; Extracellular Traps; Fumarates; Glutathione; GTP-Binding Proteins; Humans; Ionomycin; Platelet Activating Factor; Psoriasis; Reactive Oxygen Species; Superoxides; Tetradecanoylphorbol Acetate | 2018 |
Inositoylated platelet-activating factor (Ino-C2-PAF) modulates dynamic lymphocyte-endothelial cell interactions and alleviates psoriasis-like skin inflammation in two complementary mouse models.
Topics: Animals; Apoptosis; Cell Communication; Cells, Cultured; Disease Models, Animal; E-Selectin; Endothelium, Vascular; Humans; In Vitro Techniques; Inositol; Intercellular Adhesion Molecule-1; Lymphocytes; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Platelet Activating Factor; Proto-Oncogene Proteins c-jun; Psoriasis; Transcription Factors; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2014 |
Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-β1 transgenic mice.
Topics: Animals; Cytokines; Dihydropyridines; Disease Progression; Down-Regulation; Humans; Mice; Mice, Transgenic; Phenotype; Platelet Activating Factor; Platelet Membrane Glycoproteins; Psoriasis; PUVA Therapy; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Skin; STAT3 Transcription Factor; Th17 Cells; Transforming Growth Factor beta1; Up-Regulation | 2011 |
Coleus forskohlii. Monograph.
Topics: Adenosine Monophosphate; Cardiovascular Diseases; Coleus; Colforsin; Glaucoma; Hypersensitivity; Obesity; Platelet Activating Factor; Psoriasis | 2006 |
Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis.
Topics: Animals; Apoptosis; Candida albicans; Candidiasis; Combined Modality Therapy; Female; Ficusin; Humans; Hypersensitivity, Delayed; Immune Tolerance; Immunosuppression Therapy; Inflammation; Interleukin-10; Lymphoma, T-Cell, Cutaneous; Male; Mice; Mice, Knockout; Platelet Activating Factor; Platelet Membrane Glycoproteins; Psoriasis; PUVA Therapy; Receptors, G-Protein-Coupled; Signal Transduction | 2006 |
Increased monocyte chemotaxis towards leukotriene B4 and platelet activating factor in patients with inflammatory dermatoses.
Topics: Adolescent; Adult; Cells, Cultured; Chemotaxis, Leukocyte; Child; Dermatitis; Dermatitis, Atopic; Dose-Response Relationship, Immunologic; Female; Humans; Leukotriene B4; Male; Monocytes; Platelet Activating Factor; Psoriasis; Urticaria | 1983 |
Rapid isocratic high-performance liquid chromatographic purification of platelet activating factor (PAF) and lyso-PAF from human skin.
Topics: Chromatography, High Pressure Liquid; Humans; Kinetics; Platelet Activating Factor; Psoriasis; Skin; Spectrophotometry, Ultraviolet | 1984 |
Platelet activating factor (PAF) and lyso-PAF in psoriasis.
Topics: Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Psoriasis; Skin | 1994 |
[Effect of BN52021 on platelet activating factor induced aggregation of psoriatic polymorphonuclear neutrophils].
Topics: Adult; Aged; Cell Aggregation; Diterpenes; Female; Ginkgolides; Humans; Lactones; Male; Middle Aged; Neutrophils; Platelet Activating Factor; Psoriasis | 1994 |
Platelet-activating factor and arachidonic acid metabolites in psoriatic inflammation.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adolescent; Adult; Aged; Arachidonic Acid; Child; Dinoprostone; Female; Humans; Leukotrienes; Male; Middle Aged; Phospholipases A; Platelet Activating Factor; Psoriasis; Thromboxane B2 | 1996 |
Platelet activating factor in psoriasis.
Topics: Humans; Platelet Activating Factor; Psoriasis | 1997 |
Thermospray liquid chromatography/mass spectrometry of ether phosphocholines.
Topics: Chromatography, Liquid; Humans; Mass Spectrometry; Platelet Activating Factor; Psoriasis; Skin | 1986 |
Platelet activating factor in chronic plaque psoriasis.
Topics: Humans; In Vitro Techniques; Neutrophils; Platelet Activating Factor; Psoriasis; Skin | 1987 |
Identification and quantitation of PAF from psoriatic scales.
Topics: Gas Chromatography-Mass Spectrometry; Humans; Platelet Activating Factor; Psoriasis | 1987 |
Structural identification of platelet activating factor in psoriatic scale.
Topics: Animals; Biological Assay; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Gas Chromatography-Mass Spectrometry; Guinea Pigs; Humans; Platelet Activating Factor; Platelet Aggregation; Psoriasis; Skin | 1985 |